Please login to the form below

Not currently logged in


This page shows the latest risdiplam news and features for those working in and with pharma, biotech and healthcare.

New products help lift Roche outlook despite biosimilar onslaught

New products help lift Roche outlook despite biosimilar onslaught

Severin Schwan. One of the firm's most promising late-stage pipeline projects is spinal muscular atrophy (SMA) project risdiplam, which is set to rival Biogen’s Spinraza.

Latest news

More from news
Approximately 2 fully matching, plus 11 partially matching documents found.

Featured jobs

Subscribe to our email news alerts


Add my company
Nobull Communications

Switched on Creative Communications. With an encyclopedic working knowledge of pharmaceutical industry rules and regulations, we create dynamic, intuitive and...

Latest intelligence

The relevance of patient perspectives to value
Exploring the evolution of patient involvement in health technology assessment, and the role of the patient voice in market access....
How is the NHS Long-term Plan being put into action?
Steve How, Paul Midgley and Oli Hudson, of Wilmington Healthcare, explore some of the changes that have occurred since the plan was published...
real world studies
The evolution of real-world studies
How industry and regulators are using real-world data...